Home Bistro (HBIS) 10-K 14 May 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Apr. 20, 2020	Jun. 28, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	Gratitude Health, Inc.
Entity Central Index Key	0001489588
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	Yes
Entity Common Stock, Shares Outstanding		622,861,247
Entity Public Float			$ 639,723
Entity File Number	333-185083
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash	$ 115,207	$ 60,274
Accounts receivable	2,219	9,432
Inventory		60,116
Prepaid expenses and other current assets	10,511	8,939
Total Current Assets	127,937	138,761
OTHER ASSETS:
Property and equipment, net		37,487
Operating lease right-of-use assets, net	40,699
Deposit	6,828	6,828
Total Other Assets	47,527	44,315
TOTAL ASSETS	175,464	183,076
CURRENT LIABILITIES:
Accounts payable and accrued expenses	149,776	69,867
Accrued salaries and related payroll liabilities	17,620	21,745
Convertible notes payable, net of debt discount	980,648
Operating lease liabilities, current portion	25,612
Total Current Liabilities	1,173,656	91,612
Long-term liabilities:
Operating lease liabilities, less current portion	15,087
Total Liabilities	1,188,743	91,612
STOCKHOLDERS' EQUITY (DEFICIT):
Common stock ($0.001 par value: 1,000,000,000 shares authorized; 17,082,065 and 16,832,065 shares issued and outstanding as of December 31, 2019 and 2018)	17,082	16,832
Common stock to be issued (2,600,000 and none shares as of December 31, 2019 and 2018)	2,600	2,600
Additional paid-in capital	2,569,523	1,186,034
Accumulated deficit	(3,603,505)	(1,115,024)
Total Stockholders' Equity (Deficit)	(1,013,279)	91,464
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	175,464	183,076
Convertible Series A Preferred stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, value	519	520
Total Stockholders' Equity (Deficit)	519	520
Convertible Series B Preferred stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, value	500	500
Total Stockholders' Equity (Deficit)	500	500
Convertible Series C Preferred stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, value	2	2
Total Stockholders' Equity (Deficit)	$ 2	$ 2

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	17,082,065	16,832,065
Common stock, shares outstanding	17,082,065	16,832,065
Common stock to be issued	2,600,000
Convertible Series A Preferred stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	520,000	520,000
Preferred stock, shares issued	519,000	520,000
Preferred stock, shares outstanding	519,000	520,000
Convertible Series B Preferred stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000
Convertible Series C Preferred stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,500	2,500
Preferred stock, shares issued	2,250	2,250
Preferred stock, shares outstanding	2,250	2,250

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net revenues	$ 5,228	$ 18,672
Cost of sales	69,035	15,588
Gross (loss) profit	(63,807)	3,084
OPERATING EXPENSES:
Compensation and related expenses	405,326	339,274
Professional and consulting expenses	229,913	448,868
Research and development expenses	70,930	4,727
Selling and marketing expenses	62,780	11,404
General and administrative expenses	223,786	183,893
Total Operating Expenses	992,735	988,166
LOSS FROM OPERATIONS	(1,056,542)	(985,082)
OTHER INCOME (EXPENSE):
Interest income		9
Interest expense	(116,951)	(33,527)
Other expense, net	(116,951)	(33,518)
LOSS BEFORE PROVISION FOR INCOME TAXES	(1,173,493)	(1,018,600)
Provision for income taxes
NET LOSS	(1,173,493)	(1,018,600)
Deemed dividend	(1,314,988)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	$ (2,488,481)	$ (1,018,600)
NET LOSS PER COMMON SHARE
Basic and diluted	$ (0.13)	$ (0.04)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic and diluted	19,562,188	28,359,343

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	SERIES A Preferred Stock	SERIES B Preferred Stock	Series C Preferred Stock [Member]	Common Stock [Member]	Common Stock - Unissued	Additional Paid-In Capital	Retained Earnings / Accumulated Deficit	Total
Balance at Dec. 31, 2017		$ 500				$ 24,492	$ (96,424)	$ (71,432)
Balance, shares at Dec. 31, 2017		500,000
Recapitalization of the Company				$ 53,142		(76,117)		(22,975)
Recapitalization of the Company, shares				53,141,833
Cancellation of shares				$ (36,310)		36,310
Cancellation of shares,shares				(36,309,768)
Issuance of preferred stock for cash	$ 20		$ 2			451,978		452,000
Issuance of preferred stock for cash, shares	20,000		2,250
Issuance of preferred stock for cash and conversion of notes payable and accrued interest	$ 500					507,979		508,479
Issuance of preferred stock for cash and conversion of notes payable and accrued interest, shares	500,000
Unissued common stock for services					$ 2,600	231,400		234,000
Unissued common stock for services, Shares					2,600,000
Debt discount in connection with the issuance of stock warrants						9,992		9,992
Net Loss							(1,018,600)	(1,018,600)
Balance at Dec. 31, 2018	$ 520	$ 500	$ 2	$ 16,832	$ 2,600	1,186,034	(1,115,024)	91,464
Balance, shares at Dec. 31, 2018	520,000	500,000	2,250	16,832,065	2,600,000
Issuance of preferred stock for fees related to sale of preferred stock
Issuance of preferred stock for fees related to sale of preferred stock, shares			250
Beneficial conversion feature in connection with the issuance of convertible note payable						68,750		68,750
Issuance of common stock in connection with conversion of preferred stock	$ (1)			$ 250		(249)
Issuance of common stock in connection with conversion of preferred stock, Shares	(1,000)			250,000
Deemed dividend						1,314,988	(1,314,988)
Net Loss							(1,173,493)	(1,173,493)
Balance at Dec. 31, 2019	$ 519	$ 500	$ 2	$ 17,082	$ 2,600	$ 2,569,523	$ (3,603,505)	$ (1,013,279)
Balance, shares at Dec. 31, 2019	519,000	500,000	2,500	17,082,065	2,600,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,173,493)	$ (1,018,600)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	12,588	12,083
Amortization of ROU asset	22,867
Amortization of debt discount	116,848	29,703
Impairment loss	24,899
Inventory write-off	14,309	22,648
Stock-based compensation		234,000
Change in operating assets and liabilities:
Accounts receivable	7,213	(9,432)
Inventory	45,807	(82,764)
Prepaid expenses and other current assets	(1,572)	(8,939)
Advance to supplier		11,200
Deposit		(6,828)
Accounts payable and accrued expenses	79,909	36,325
Accrued salaries and related payroll liabilities	(4,125)	21,745
Operating lease liabilities	(22,867)
NET CASH USED IN OPERATING ACTIVITIES	(877,617)	(758,859)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of equipment		(36,348)
NET CASH USED IN INVESTING ACTIVITIES		(36,348)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds received from issuance of convertible notes payable, net of issuance cost	932,550	120,000
Net proceeds received from issuance of preferred stock		715,000
Repayments on advances from related parties		(345)
NET CASH PROVIDED BY FINANCING ACTIVITIES	932,550	834,655
NET INCREASE IN CASH	54,933	39,448
CASH, beginning of year	60,274	20,826
CASH, end of year	115,207	60,274
Cash paid during the period for:
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Beneficial conversion feature in connection with the issuance of convertible notes payable	68,750
Operating lease right-of-use assets and operating lease liabilities recorded upon adoption of ASC 842	63,566
Issuance of preferred stock for conversion of notes payable and accrued interest		245,479
Assumption of liabilities in connection with the reverse merger		$ 22,975

Organization and Operations

Organization and Operations	12 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Operations	Note 1 - Organization and Operations Gratitude Health, Inc., (the "Company", formerly Vapir Enterprises, Inc.) was incorporated in the State of Nevada on December 17, 2009. Effective March 23, 2018, the Company changed its legal name to Gratitude Health, Inc. from Vapir Enterprises Inc. On March 26, 2018, the Company merged with Gratitude Health Inc. ("Gratitude Subsidiary"), a private company incorporated in Florida on September 14, 2017, in a transaction treated as a reverse acquisition and recapitalization effected by a share exchange. The consolidated financial statements are those of Gratitude Subsidiary (the accounting acquirer) prior to the merger and reflect the consolidated operations of the Company (the legal acquirer) from the date of the merger. The equity of the consolidated entity is the historical equity of Gratitude Subsidiary retroactively restated to reflect the number of shares issued by the Company in the reverse acquisition. The Company's former business was focused on inventing, developing and producing aromatherapy devices and vaporizers before the merger. The Company is now engaged in manufacturing, selling and marketing functional RTD (Ready to Drink) beverages sold under the Company's trademark. Share Exchange Agreement On March 26, 2018, Gratitude Health, Inc. f/ka Vapir Enterprises, Inc., a corporation organized under the laws of Nevada (the "Acquiror" or the "Company"), Hamid Emarlou, the principal shareholder of the Acquiror (the "Acquiror Principal Shareholder"), Gratitude Health, Inc., a corporation organized under the laws of Florida (the "Acquiree" or "Gratitude Subsidiary"), and each of the Persons who are shareholders of the Acquiree (collectively, the "Acquiree Shareholders," and individually an "Acquiree Shareholder") entered into a Share Exchange Agreement pursuant to which the Acquiree Shareholders (who are the holders of all the issued and outstanding shares of common stock of the Acquiree (the "Acquiree Interests") agreed to transfer to the Acquiror, and the Acquiror agreed to acquire from the Acquiree Shareholders, all of the Acquiree Interests, in exchange for the issuance of 520,000 shares of Series A Preferred Stock and 500,000 shares of Series B Preferred Stock, to the Acquiree Shareholders (the "Acquiror Shares"), which Acquiror Shares shall, upon conversion into 102,000,000 shares of common stock of the Acquiror, constitute approximately 85.84% on a fully diluted basis of the issued and outstanding shares of Acquiror common stock immediately after the closing of the transactions on the terms and conditions as set forth in the Exchange Agreement and the closing of the Spin Off Agreement as described below. Effective March 26, 2018, the Company acquired all the issued and outstanding shares of the Acquiree pursuant to the Exchange Agreement and the Acquiree became the Company's wholly-owned subsidiary. As a result of the Exchange Agreement, for financial statement reporting purposes, the business combination between the Company and Acquiree has been treated as a reverse acquisition and recapitalization with the Acquiree deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification ("ASC") Section 805-10-55. At the time of the Exchange Agreement, both the Company and Acquiror had their own separate operating segments. Accordingly, the assets and liabilities and the historical operations that are reflected in the consolidated financial statements after the Exchange Agreement are those of the Acquiree and are recorded at the historical cost basis of the Acquiree. The acquisition process utilizes the capital structure of the Company and the assets and liabilities of the Acquiree which are recorded at historical cost. The results of operations of the Company are consolidated with results of operations of the Acquiree starting on the date of the Exchange Agreement. The equity of the consolidated entity is the historical equity of Gratitude Subsidiary retroactively restated to reflect the number of shares issued by the Company in the reverse acquisition. The Merger has constituted a change of control or change in control, the majority of the Board of Directors changed with the consummation of the Merger. The Company issued to Acquiree shares of preferred stock which represented approximately 86% of the combined company on a fully converted basis after the closing of the Exchange Agreement and the Spin off Agreement as described below. On the Closing Date, Acquiror Principal Shareholder entered into a Spin Off Agreement with Acquiror for the sale of the existing wholly owned Vapir, Inc. subsidiary of the Company in exchange for Acquiror Principal Shareholder's 36,309,768 shares of Common Stock. The Spin Off Agreement closed on April 14, 2018. As such, the Company recognized the disposition of the Vapir business on the date of merger. In March 2018, in connection with the Exchange Agreement, the Company issued 20,000 Series A Preferred stock for purchase price of $2,000. In March 2018, in connection with the Exchange Agreement, the Company issued 500,000 Series A Preferred Stock for a purchase price of (i) $3,000 cash, (ii) the satisfaction of the convertible notes including accrued interest of $5,479 and total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holder pursuant to the Surrender and Exchange Agreement, (see Note 6) (iii) $260,000 additional funding in cash after the closing of an Exchange Agreement which is recorded as subscription receivable and (iv) the surrender and cancellation of certain notes and warrants owed by the Company prior to the merger pursuant to the Surrender and Exchange Agreement dated in March 2018 for a principal amount of $172,500 and accrued interest of $76,157. The subscription receivable of $260,000 was collected in April 2018. Such surrender of notes and warrants were done in connection with the Exchange Agreement which closed on March 26, 2018. In connection with the Exchange Agreement, the Company issued 500,000 shares of Series B Preferred Stock to the founders who were the CEO and COO of the Company.

Significant and Critical Accoun

Significant and Critical Accounting Policies and Practices	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Significant and Critical Accounting Policies and Practices	Note 2 - Significant and Critical Accounting Policies and Practices Basis of Presentation and principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and in accordance with Regulation S-X of the Securities and Exchange Commission (the "SEC"). The consolidated financial statements present the consolidated financial statements of the Company and its wholly-owned subsidiary as of December 31, 2019 and 2018. All intercompany transactions and balances have been eliminated. These consolidated financial statements for the years ended December 31, 2019 and 2018 consist of the consolidated balance sheets of the Company as of December 31, 2019 and 2018, and the related consolidated statements of operations, statements of changes in stockholders' equity (deficit), and statements of cash flows for the years ended December 31, 2019 and 2018, and related notes, and accordingly do not reflect the acquisition of our new wholly-owned subsidiary, Home Bistro, which was consummated on April 20, 2020, as more fully disclosed in Note 13. Use of Estimates and Assumptions and Critical Accounting Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated balance sheet, and revenues and expenses for the period then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to valuation of deferred tax assets and valuation of debt discounts. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassified amounts have no impact on the Company's previously reported financial position or results of operations. Cash and cash equivalents The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company held no cash equivalents as of December 31, 2019 and 2018. The Company maintains cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. The Company's account at this institution is insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. As of December 31, 2019 and 2018, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Fair value of financial instruments The estimated fair value of certain financial instruments, including cash, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses, accrued salaries and related payroll liabilities, and convertible notes payable are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. Inventory The Company values inventory, consisting of finished goods and raw materials, at the lower of cost or net realizable value. Cost is determined on the first-in and first-out ("FIFO") method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of the estimated net realizable value include (i) estimates of future demand, and (ii) competitive pricing pressures. The Company recorded inventory write-off and spoilage of $14,309 and $0 during the year ended December 31, 2019 and 2018, respectively. Property and Equipment Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets of 3 years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired, or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the consolidated statement of operations. Revenue Recognition On January 1, 2018, the Company adopted the Accounting Standard Codification ("ASC") Topic 606 and the related amendments Revenue from Contracts with Customers, which requires revenue to be recognized in a manner that depicts the transfer of goods or services to customers in amounts that reflect the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company recognizes revenue by applying the following steps: Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. The Company's performance obligations are satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company's contracts have a single performance obligation (shipment or delivery of product). The Company primarily receives fixed consideration for sales of product. Cost of Sales The primary components of cost of sales include the cost of the product, production costs, warehouse storage costs and shipping fees. Research and development Research and development costs incurred in the development of the Company's products are expensed as incurred. During the years ended December 31, 2019 and 2018, research and development costs were $70,930 and $4,727, respectively. Shipping and Handling Costs The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in selling and marketing expenses as incurred. Shipping costs included in selling and marketing expenses were $3,090 and $1,500 for the year ended December 31, 2019 and 2018, respectively. Advertising Costs The Company applies ASC 720 "Other Expenses" to account for advertising related costs. Pursuant to ASC 720-35-25-1, the Company expenses the advertising costs the first time the advertising takes place. Advertising costs were $48,690 and $13,089 for the year ended December 31, 2019 and 2018, respectively, and was included in selling and marketing expenses. Stock-based compensation Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Through March 31, 2018, pursuant to ASC 505-50 - Equity-Based Payments to Non-Employees, all share-based payments to non-employees, including grants of stock options, were recognized in the consolidated financial statements as compensation expense over the service period of the consulting arrangement or until performance conditions were expected to be met. Using a Black Scholes valuation model, the Company periodically reassessed the fair value of non-employee options until service conditions were met, which generally aligned with the vesting period of the options, and the Company adjusted the expense recognized in the consolidated financial statements accordingly. In June 2018, the FASB issued ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting, which simplifies several aspects of the accounting for nonemployee share-based payment transactions by expanding the scope of the stock-based compensation guidance in ASC 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU No. 2018-07 is effective for annual periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption is permitted, but entities may not adopt prior to adopting the new revenue recognition guidance in ASC 606. Effective April 1, 2018, the Company adopted ASU No. 2018-07 which did not have any material impact on the Company's consolidated financial statements. Leases In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases On January 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assessed whether the contract is, or contains, a lease. The Company's assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Operating lease right of use assets ("ROU") assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses in the condensed consolidated statements of operations. Income Taxes The Company accounts for income taxes pursuant to the provision of ASC 740-10, "Accounting for Income Taxes" ("ASC 740-10"), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25, "Definition of Settlement", which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed. Impairment of long-lived assets The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset's estimated fair value and its book value. The Company recorded impairment expense of $24,899 and $0 during the year ended December 31, 2019 and 2018, respectively. The Company impaired the net book value of $24,899 related to equipment used for the production of the ready to drink tea beverage as the Company has shifted its focus on the product development of the Company's Keto complete meal beverage and was included in general and administrative expenses as reflected in the consolidated statements of operations. Basic and diluted net loss per share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The potentially dilutive common stock equivalents for the year ended December 31, 2019 and 2018 were excluded from the dilutive loss per share calculation as they would be antidilutive due to the net loss. The following were the computation of diluted shares outstanding and in periods where the Company has a net loss, all dilutive securities are excluded. December 31, December 31, Common stock equivalents: Stock options 1,940,000 1,940,000 Convertible notes payable 26,125,000 - Convertible Preferred Stock 267,250,000 111,000,000 Total 295,315,000 112,940,000 Recent accounting pronouncements In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)". The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. The new guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods and is applied retrospectively. The Company elected to apply the transition provisions as of January 1, 2019, the date of adoption, and recorded lease ROU assets and related liabilities on the consolidated balance sheet related to our operating leases. In July 2017, the FASB issued ASU 2017-11 "Earnings Per Share (Topic 260)". The amendments in the update change the classification of certain equity-linked financial instruments (or embedded features) with down round features. The amendments also clarify existing disclosure requirements for equity-classified instruments. For freestanding equity-classified financial instruments, the amendments require entities that present earnings per share ("EPS") in accordance with Topic 260, Earnings Per Share, to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features would be subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 with early adoption permitted. The Company adopted this pronouncement as of fiscal 2017 and applied it to the convertible notes payable issued in March and May of 2019 that include down round features. During the year ended December 31, 2019, a down round feature present in a convertible note payable and convertible preferred stock was triggered (see Notes 7 and 8). In June 2018, the FASB issued ASU No. 2018-07 "Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting." These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The ASU supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. The guidance is effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than a company's adoption date of Topic 606, Revenue from Contracts with Customers. The adoption of this guidance had no material impact on its accounting and disclosures. In August 2018, the FASB issued ASU 2018-13, "Changes to Disclosure Requirements for Fair Value Measurements", which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements, and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The adoption of this guidance had no material impact on its accounting and disclosures. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2019
Going Concern [Abstract]
Going Concern	Note 3 - Going Concern The Company's consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the consolidated financial statements, the Company has an approximate accumulated deficit and working capital deficit of approximately $3,604,000 and $1,046,000 at December 31, 2019, respectively, and incurred a net loss of approximately $1,173,000 and used cash in operating activities of approximately $878,000 for the year ended December 31, 2019. These circumstances raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the date of this report. The ability of the Company to continue as a going concern is dependent on the Company's ability to implement its business plan, raise capital, and generate sufficient revenues. Currently, management is seeking capital to implement its business plan and generate sufficient revenues. There is no guarantee that the Company will be able to raise sufficient capital or generate a level of revenues to sustain its operations. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2019
Inventory Disclosure [Abstract]
Inventory	Note 4 - Inventory Inventory consisted of the following: December 31, December 31, Finished goods $ - $ 39,984 Raw materials - 20,132 $ - $ 60,116 At December 31, 2019 and 2018, inventory held at third party locations amounted to $0 and $60,116, respectively. During the year ended December 31, 2019, there were $14,309 inventory write-offs included in cost of sales. The write-offs are related to spoilage and the value of the remaining cost of raw materials for the Company's ready to drink tea beverage as the Company has shifted its focus on the product development of the Company's Keto Fuel complete meal beverages and has stopped selling and marketing the ready to drink tea beverage. During the year ended December 31, 2018, the Company wrote off inventory for spoilage of $22,648 prior to generating any revenue and recorded the expense to general and administrative expenses on the statements of operations.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 5 - Property and Equipment Property and equipment consisted of the following: Estimated life As of As of Molding Tool equipment 3 years $ 30,592 $ 30,592 Packing equipment 3 years 19,756 19,756 Less: Accumulated depreciation (25,449 ) (12,861 ) Net book value (24,899 ) - Less: Impairment loss (24,899 ) - $ - $ 37,487 Depreciation expense amounted to $12,588 and $12,083 for the years ended December 31, 2019 and 2018, respectively. Additionally, the Company recognized an impairment loss of $24,899 related to the net book value of equipment used for the production of the ready to drink tea beverage as the Company has shifted its focus on the product development of the Company's Keto Fuel complete meal beverages and therefore recorded an impairment loss of $24,899 which is included in general and administrative expenses in the consolidated statement of operations during the year ended December 31, 2019.

Operating Lease Right-of-Use As

Operating Lease Right-of-Use Assets and Operating Lease Liabilities	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Operating Lease Right-of-Use Assets and Operating Lease Liabilities	Note 6 – Operating Lease Right-of-Use Assets and Operating Lease Liabilities In April 2018, the Company entered into a lease agreement for its corporate facility in Palm Beach Gardens, Florida. The lease is for a period of 36 months commencing in July 2018 and expiring in July 2021. Pursuant to the lease agreement, the lease requires the Company to pay a monthly base rent of $2,154 plus a pro rata share of operating expenses beginning July 2018 and subject to annual increases beginning the 2nd and 3rd lease year. In addition to the monthly base rent, we are charged separately for common area maintenance which is considered a non-lease component. These non-lease component payments are expensed as incurred and are not included in operating lease assets or liabilities. In March 2019, the Company entered into an equipment lease agreement for a copier on March 27, 2019 expiring March 27, 2022 and requiring monthly payments of $145 with an option to purchase the equipment at fair market value at the end of the lease term. In adopting ASC Topic 842, Leases (Topic 842), the Company has elected the 'package of practical expedients', which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 month or less. On January 1, 2019, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $63,566. Right-of- use assets are summarized below: December 31, 2019 Office lease (remaining lease term of 18 months) $ 59,069 Equipment lease (remaining lease term of 27 months) 4,497 Subtotal 63,566 Less accumulated amortization (22,867 ) Right-of-use assets, net $ 40,699 Operating Lease liabilities are summarized below: December 31, 2019 Office lease $ 59,069 Equipment lease 4,497 Reduction of lease liability (22,867 ) Total lease liabilities 40,699 Less: current portion (25,612 ) Long term portion of lease liability $ 15,087 Minimum lease payments under non-cancelable operating lease at December 31, 2019 are as follows: Year ended December 31, 2020 $ 28,764 Year ended December 31, 2021 15,450 Year ended December 31, 2022 435 Total $ 44,649 Less: present value discount (3,950 ) Total operating lease liability $ 40,699

Note Payable and Convertible No

Note Payable and Convertible Notes Payable	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Note payable and Convertible Notes Payable	Note 7 – Note payable and Convertible Notes Payable Convertible note payable consisted of the following: December 31, December 31, Convertible notes payable $ 1,045,000 $ - Unamortized debt discount (64,352 ) - Total convertible notes payable $ 980,648 $ - Between January 2018 to March 2018, the Company through the Company's wholly owned subsidiary, Gratitude Subsidiary, entered into promissory note agreements, providing for the issuance of notes in the principal amount of $120,000 to an unrelated party pursuant to a Securities Purchase Agreement. The notes were due one year from the date of issuance. The annual interest rate for the notes were 12%. The notes were convertible any time after the issuance date of the note at $0.01 per share. The Company granted the note holder an aggregate of 12,000,000 warrants in connection with the issuance of these notes. The warrants had a term of 5 years from the date of grant and was exercisable at an exercise price of $0.02. The Company accounted for the warrants by using the relative fair value method. The debt discount consisted of relative fair value of the warrants of $9,992 using a Black-Scholes model with the following assumptions: dividend yield of zero, years to maturity of 5.00, a risk-free rate of 2.00%, and expected volatility of 200% using volatilities of similar companies. In connection with the merger, the Company entered into a Surrender and Exchange Agreement with these note holders whereby the note holders agreed to surrender the 12% convertible notes including accrued interest of $5,479 and the total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holders in exchange for Series A Preferred Stock. Such surrender of notes and warrants was done in connection with the Exchange Agreement which closed on March 26, 2018 (see Note 1). Accordingly, the Company fully amortized the debt discount of $29,703 for the year ended December 31, 2018 and such 24,000,000 warrants granted by Gratitude Subsidiary were cancelled as of December 31, 2018. As of December 31, 2018, principal amount of the notes and accrued interest outstanding was $0. On February 13, 2019, the Company issued an unsecured promissory note for principal borrowings of $50,000. The 10% promissory note and all accrued interest were due on February 22, 2019. Any amount of principal or interest on this promissory note which was not paid when due would bear interest at the rate of 20% per annum from the due date. In March 2019, this note was repaid in full using proceeds from the issuance of a convertible note as discussed below. On March 7, 2019 and on May 14, 2019, the Company closed a financing transaction by entering into a Securities Purchase Agreement (the " Securities Purchase Agreement ") with an accredited investor for purchase of a promissory note (the "Note" and with other notes issued under the Securities Purchase Agreement, the "Notes") an aggregate principal amount of $550,000 and gross cash proceeds of $500,000 (out of an aggregate of up to $550,000 principal amount of Notes representing $1.10 of note principal for each $1.00 of proceeds which can be purchased in subsequent closings in minimum amounts of $25,000). The March 7, 2019 and May 14, 2019 promissory notes were convertible into common stock of the Company at an initial conversion price of $0.05 and $0.04, respectively, which is subject to price protection, whereby upon any issuance of securities of the Company at a price below the effective conversion price of the Notes is adjusted to the new lower issuance price ("Down Round Feature"). The Notes have a term of one year from the date of issuance. The Company received gross proceeds of $500,000 of which $50,000 was used to pay the promissory note issued in February 2019 (see above). See below for trigger of this Down Round Feature when the conversion price on the March 7, 2019 Securities Purchase Agreement was reduced from $0.05 to $0.04. On August 12, 2019, the Company entered into an Allonge Agreement with a lender whereby the principal amount of a convertible note dated on March 7, 2019 was increased by $137,500 ("Allonge Principal") with original issue discount of 10%, receiving gross cash proceeds of $125,000. The maturity date with respect to the Allonge Principal shall also be on March 7, 2020 and all the terms of the Note dated on March 7, 2019 remain as originally stated except the Allonge Principal is convertible into common stock of the Company at an initial conversion rate of $0.04, subject to price protection. The Company determined that there was no beneficial conversion feature as the effective conversion price is greater than the fair value of common stock shares on date of issuance. On October 11, 2019, the Company entered into a Second Allonge Agreement with a lender whereby the principal amount of a convertible note dated on March 7, 2019 was increased by another $110,000 ("Second Allonge Principal") with original issue discount of 10%, receiving gross cash proceeds of $100,000. The maturity date with respect to the Second Allonge Principal shall also be on March 7, 2020 and all the terms of the Note dated on March 7, 2019 remain as originally stated. The Company determined that there was no beneficial conversion feature as the effective conversion price is greater than the fair value of convertible instrument related to the Second Allonge Principal. On November 19, 2019, the Company entered into a Third Allonge Agreement with a lender whereby the principal amount of a convertible note dated on March 7, 2019 was increased by another $247,500 ("Third Allonge Principal") with original issue discount of 10%, receiving gross cash proceeds of $225,000. The maturity date with respect to the Third Allonge Principal shall also be on March 7, 2020 and all the terms of the Note dated on March 7, 2019 remain as originally stated. The Company determined that there was no beneficial conversion feature as the effective conversion price is greater than the fair value of convertible instrument related to the Third Allonge Principal. The Company accounted for the beneficial conversion features based on the intrinsic value on date of issuance. The debt discounts consisted of beneficial conversion features of $68,750, financing costs of $14,950, legal fees of $2,500 and debt premium of $95,000 which is being amortized over the term of the notes. During the year ended December 31, 2019 and 2018, the Company recorded $116,848 and $0, respectively, as amortization of debt discount which is included in interest expense in the consolidated statements of operations. As of December 31, 2019 and 2018, there was unamortized discounts of $64,352 and $0. The Down Round Feature was triggered on May 14, 2019 when the conversion price of the March 7, 2019 convertible note payable was reduced from $0.05 to $0.04 as discussed. In accordance with ASU 2017-11 "Earnings Per Share (Topic 260)", the Company measured the incremental intrinsic value of the effect of the feature upon the Down Round Feature being triggered based on the additional shares to be issued upon conversion due to the reduction in the conversion price and fair value of the stock on the commitment date of March 7, 2019. This difference of $72,188 has been recorded as a deemed dividend and has been reduced from the net loss available to common stockholders. Subsequent to December 31, 2019, all convertible notes payable outstanding as of December 31, 2019 were exchanged for warrants to purchase up to 26,125,000 shares of common stock (see Note 13).

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Stockholders' Equity (Deficit)	Note 8 - Stockholders' Equity (Deficit) Shares Authorized The authorized capital of the Company consists of 300,000,000 shares of common stock, par value $0.001 per share and 20,000,000 shares of preferred stock, par value $0.001 per share. On August 9, 2019, the Board of Directors of the Company approved to increase the authorized shares of the Company's common stock to 600,000,000 shares from 300,000,000 shares of authorized shares of common stock. Subsequent to December 31, 2019, the Company approved an increase to its authorized shares to 1,000,000,000. Preferred Stock On March 19, 2018, the Company designated 520,000 shares of Series A Preferred Stock, par value $0.001 per share (the "Series A Preferred Stock"). Each share of Series A Preferred Stock is convertible into shares of the Company's common stock with a stated value of $10 per share of Series A Preferred Stock and the initial conversion price of $0.10 per share subject to adjustment in the event of stock split, stock dividends, subsequent equity sales with lower effective price, and recapitalization or otherwise and was adjusted down to $0.04 on May 14, 2019 due to a trigger event that occurred (see Note 7). The holders of the Series A Preferred Stock shall not possess any voting rights. The Series A Preferred Stock does not contain any redemption provision. The Series A Preferred Stock are entitled to receive in cash out of assets of the Company before any amounts shall be paid to the holders of any of shares of junior stock, an amount equal to the stated value plus any accrued and unpaid dividends thereon and any other fees due and owing. On March 19, 2018, the Company designated 500,000 shares of Series B Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"). Each share of Series B Preferred Stock is convertible into shares of the Company's common stock with a stated value of $10 per share of Series B Preferred Stock and the initial conversion price of $0.10 per share subject to adjustment in the event of stock split, stock dividends, subsequent equity sales with lower effective price, and recapitalization or otherwise and was adjusted down to $0.04 on May 14, 2019 due to a trigger event that occurred (see Note 7). The Series B Preferred Stock votes with the common stock on a fully as converted basis. The Series B Preferred Stock does not contain any redemption provision. The Series B Preferred Stock are entitled to receive in cash out of assets of the Company before any amounts shall be paid to the holders of any of shares of junior stock, an amount equal to the stated value plus any accrued and unpaid dividends thereon and any other fees due and owing. On August 1, 2018, the Company designated 1,000 shares of Series C Preferred Stock, par value $0.001 per share (the "Series C Preferred Stock"). Each share of Series C Preferred Stock is convertible into shares of the Company's common stock with a stated value of $200 per share of Series C Preferred Stock and the initial conversion price of $0.05 per share subject to adjustment in the event of stock split, stock dividends, subsequent equity sales with lower effective price, and recapitalization or otherwise and was adjusted down to $0.04 on May 14, 2019 due to a trigger event that occurred (see Note 7). The Series C Preferred Stock votes with the common stock on a fully as converted basis. The Series C Preferred Stock does not contain any redemption provision. The Series C Preferred Stock are entitled to receive in cash out of assets of the Company before any amounts shall be paid to the holders of any of shares of junior stock, an amount equal to the stated value plus any accrued and unpaid dividends thereon and any other fees due and owing. In October 2018, the Board of Directors of the Company approved and authorized an amendment to increase the number of designated authorized shares of the Series C preferred stock from 1,000 to 2,500 shares. The Down Round Feature embedded in all Series of Preferred Stock was triggered on May 14, 2019 when the conversion price of the May 14, 2019 convertible note payable was issued at $0.04 (see Note 7). The Company measured the value of the effect of the feature upon the Down Round Feature being triggered based on the incremental intrinsic value that resulted from triggering the Down Round Feature which was measured as the additional common stock shares that would be issued upon conversion due to the reduction in the conversion rate and the intrinsic value on the trigger date of May 14, 2019. This difference of $1,242,800 has been recorded as a deemed dividend and has been reduced from the net loss available to common stockholders. Sale of Preferred Stock In March 2018, in connection with the Exchange Agreement, the Company issued 20,000 Series A Preferred stock for purchase price of $2,000. In March 2018, in connection with the Exchange Agreement, the Company received gross proceeds for a total of $263,000 for the issuance of 490,000 Series A Preferred Stock (see note above). In August 2018, the Company sold 750 shares of Series C Preferred stock for total proceeds of $150,000. Additionally, the Company issued 250 shares of Series C Preferred stock as due diligence fee in connection with this Series C Preferred stock sale and was recorded at par value during the year ended December 31, 2019. In October 2018, the Company sold 750 shares of Series C Preferred stock for total proceeds of $150,000. In December 2018, the Company sold 750 shares of Series C Preferred stock for total proceeds of $150,000. Common Stock In connection with the Exchange Agreement, the Company is deemed to have issued 53,141,833 shares of common stock which represents the outstanding common shares of the Company prior to the closing of the Merger. In connection with the Spin Off Agreement which closed on April 14, 2018, the Company cancelled the 36,309,768 shares. In April 2018, the Company granted an aggregate of 2,600,000 shares of the Company's common stock to various consultants and service providers for services rendered. The Company valued these common shares at the fair value of $234,000 or $0.09 per common share based on the closing trading price on the date of grant. The Company recorded stock-based compensation of $234,000 during the year ended December 31, 2018. In connection with these transactions, there were 2,600,000 shares of common stock to be issued as of December 31, 2019 and 2018. In June 2019, the Company issued 250,000 shares of the Company's common stock in exchange for the conversion of 1,000 shares of the Company's Series A Preferred Stock. Common Stock Options Stock option activity for the year ended December 31, 2018 is summarized as follows: Number of Weighted Weighted Aggregate Balance at December 31, 2017 - - - - Recapitalization on March 26, 2018 1,940,000 0.10 2.80 - Balance at December 31, 2018 1,940,000 0.10 2.79 - Options exercisable at December 31, 2018 1,940,000 $ 0.10 2.04 $ - Stock option activity for the year ended December 31, 2019 is summarized as follows: Number of Weighted Weighted Aggregate Balance at December 31, 2018 1,940,000 0.10 2.04 - Balance at December 31, 2019 1,940,000 0.10 1.04 - Options exercisable at December 31, 2019 1,940,000 $ 0.10 1.04 $ - As of December 31, 2019 and 2018, all outstanding options are fully vested and there was no unrecognized compensation expense in connection with unvested stock options. Common Stock Warrants A summary of the Company's outstanding stock warrants as of December 31, 2018 and changes during the period presented below: Number of Weighted Weighted Balance at December 31, 2017 12,000,000 $ 0.02 4.85 Granted 12,000,000 0.02 5.00 Cancelled (24,000,000 ) 0.10 4.70 Balance at December 31, 2018 - $ - - Warrants exercisable at December 31, 2018 - $ - - Weighted average fair value of warrants granted during the year ended December 31, 2018 $ 0.001 In March 2018 in connection with the merger, the Company entered into Surrender and Exchange Agreements with note holders whereby the note holders agreed to surrender the 12% convertible notes including accrued interest of $5,479 and a total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holders. Such surrender of notes and warrants was done in connection with the Exchange Agreement which closed on March 26, 2018 (see Note 7). There were no changes related to stock warrants during the year ended December 31, 2019.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9 - Commitments and Contingencies License Agreement In January 2018, the Company entered into a Standard Exclusive License Agreement (the "License Agreement") whereby the licensor agreed to grant exclusive license to the Company for licensed patent owned or controlled by licensor. The licensed patent is related to tea polyphenols esters and analogs for cancer prevention and treatment. The term of this license shall begin on the effective date of this License Agreement and continue until the later of the date that no licensed patent remains a pending application or an enforceable patent, or the date on which Company's obligation to pay royalties expires pursuant to the License Agreement. If the Company has not pursued a market or territory respecting the licensed patents within one year of the date of execution of this License Agreement and Licensor has received notice that a third party wishes to negotiate a license for such market or territory, Licensor may terminate the license granted in with respect to such market or territory upon sixty (60) days written notice to Licensee. The Company agreed to pay license issue fee of $5,000 within 30 days of the effective date which was paid in March 2018. Additionally, the Company agreed to pay certain royalty payments as follows: (i) three percent (3%) for Net Sales of Licensed Products, and Licensed Processes (all as defined in the License Agreement), for each product or process, on a country-by-country basis, for cumulative Net Sales up to one million dollars ($1,000,000); and (ii) four percent (4%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, for cumulative Net Sales from one million dollars ($1,000,000) to five million dollars ($5,000,000); and (iii) five percent (5%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, Net Sales over five million dollars ($5,000,000). Furthermore, the Company agrees to pay Licensor minimum royalty payments, as follows: Payment Year $ 20,000 2018 $ 50,000 2019 $ 100,000 2020 and every year thereafter on the same date, for the life of this License Agreement. The minimum royalty shall be paid in advance on a quarterly basis for each year in which this License Agreement is in effect. The first minimum royalty payment was due on March 31 st

Concentrations of Revenue and S

Concentrations of Revenue and Supplier	12 Months Ended
	Dec. 31, 2019
Risks and Uncertainties [Abstract]
Concentrations of Revenue and Supplier	Note 10 – Concentrations of Revenue and Supplier During the year ended December 31, 2019, beverage sales to two customers represented approximately 95% of the Company's net sales. During the year ended December 31, 2018, beverage sales to a customer represented approximately 99% of the Company's net sales. As of December 31, 2019, accounts receivable from two customers represented approximately 100% of total accounts receivable. As of December 31, 2018, accounts receivable from one customer represented approximately 98% of total accounts receivable. During the year ended December 31, 2019, the Company purchased raw materials and products from two vendors totaling approximately $3,424 (100% of the purchases). During the year ended December 31, 2018, the Company purchased inventories and products from two vendors totaling approximately $65,900 (45% of the purchases at 12% and 33%).

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Note 11 - Related Party Transactions In connection with the Exchange Agreement (see Note 1), the Company issued 500,000 shares of Series B Preferred Stock to the founders who were the CEO and COO of the Company. In April 2018, the Company granted 100,000 shares of the Company's common stock to the son of the former CEO of the Company who is now the COO of the Company for services rendered (see Note 8). The Company valued these common shares at the fair value of $9,000 or $0.09 per common share based on the closing trading price on the date of grant. The Company recorded stock-based compensation of $9,000 during the year ended December 31, 2018. These shares were to be issued as of December 31, 2019.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Note 12 – Income Taxes On December 22, 2017, the Tax Cuts and Jobs Act (the "Act") was signed into law. The Act decreased the U.S. corporate federal income tax rate from a maximum of 35% to a flat 21% effective January 1, 2018. The Act also includes a number of other provisions including, among others, the elimination of net operating loss carrybacks and limitations on the use of future losses, the repeal of the Alternative Minimum Tax regime and the repeal of the domestic production activities deduction. These provisions are not expected to have a material effect on the Corporation. Given the significant complexity of the Act and anticipated additional implementation guidance from the Internal Revenue Service, further implications of the Act may be identified in future periods. The Company has incurred aggregate net operating losses of approximately $1,891,301 for income tax purposes as of December 31, 2019 that can be utilized indefinitely to reduce future United States taxable income subject to annual usage limits. Management believes that the realization of the benefits from these losses appears not more than likely due to the Company's limited operating history and continuing losses for United States income tax purposes. Accordingly, the Company has provided a 100% valuation allowance on the deferred tax asset to reduce the asset to zero. Management will review this valuation allowance periodically and make adjustments as necessary. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes were as follows: Year Ended December 31, 2019 Year Ended December 31, 2018 Income tax benefit at U.S. statutory rate of 21% $ (246,434 ) $ (213,906 ) Non-deductible expenses 24,538 55,378 Increase in valuation allowance 221,896 158,528 Total provision for income tax $ - $ - The Company's approximate net deferred tax asset was as follows: Deferred Tax Asset: December 31, 2019 December 31, 2018 Net operating loss carryforward $ 397,173 $ 175,277 Valuation allowance (397,173 ) (175,277 ) Net deferred tax asset $ - $ - The Company provided a valuation allowance equal to the deferred income tax asset for the year ended December 31, 2019 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The increase in the allowance was $221,896 in fiscal 2019. Additionally, the future utilization of the net operating loss carryforward to offset future taxable income may be subject to an annual limitation as a result of the recent tax law and ownership changes that could occur in the future. The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position. The Company's 2017, 2018 and 2019 Corporate Income Tax Returns are subject to Internal Revenue Service examination.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent events	Note 13 – Subsequent events On January 30, 2020, the Company entered into a Second Allonge Agreement with a lender whereby the principal amount of a convertible note dated on March 7, 2019 was increased by another $82,500 ("Fourth Allonge Principal") with original issue discount of 10%, receiving gross cash proceeds of $75,000. The maturity date with respect to the Fourth Allonge Principal shall also be on March 7, 2020 and all the terms of the Note dated on March 7, 2019 remain as originally stated (see Note 7). The Company determined that there was no beneficial conversion feature as the effective conversion price is greater than the fair value of convertible instrument related to the Fourth Allonge Principal. On March 24, 2020, the Company sold 2,500,000 shares of the Company's common stock for gross proceed of $25,000. On April 7, 2020, the Board of Directors of the Company approved to increase the authorized shares of the Company's common stock to 1,000,000,000 shares from 600,000,000 shares of authorized shares of common stock. On April 20, 2020, the Company, Fresh Market Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company ("Merger Sub"), and Home Bistro, Inc., a privately-held Delaware corporation engaged in the food preparation and home-delivery business ("Home Bistro"), entered into an Agreement and Plan of Merger (the "Merger Agreement") pursuant to which, among other things, Merger Sub agreed to merge with and into Home Bistro, with Home Bistro becoming a wholly-owned subsidiary of the Company and the surviving corporation in the merger (the "Merger"). Prior to the effective time of the Merger, the Company and certain of its existing securityholders entered into an Exchange Agreement providing for, among other things, the exchange (the "Exchange") of securities held by such securityholders for shares of the Company's common stock, par value $0.001 per share, as more fully detailed therein. As a result of the Exchange, all of the Company's issued and outstanding shares of Series A Convertible Preferred Stock, Series C Convertible Preferred Stock, stock options and Convertible Notes Payable (see Note 7) were converted into an aggregate of 172,377,500 shares of common stock on a fully diluted basis, consisting of 56,831,789 shares of the Company's common stock and warrants to purchase up to 115,545,711 shares of Common Stock. The 250,000 shares of Series B Convertible Preferred Stock remain issued and outstanding and the other 250,000 shares of Series B Convertible Preferred Stock owned by a former officer were cancelled on April 9, 2020 pursuant to a General Release Agreement. At the effective time of the Merger, and subject to the terms and conditions of the Merger Agreement, each outstanding share of common stock of Home Bistro was converted into the right to receive fifteen thousand one hundred and point three (15,100.3) shares of common stock of the Company. Accordingly, the aggregate consideration issuable in the Merger to the former securityholders of Home Bistro is 767,838,260 shares of common stock on a fully-diluted basis consisting of 546,447,393 shares of common stock and warrants to purchase up to 221,390,867 shares of Common Stock. As a result of the Merger, the Company has 959,797,825 shares of common stock issued and outstanding on a fully-diluted basis consisting of 622,861,247 shares of common stock and warrants to purchase up to 336,936,578 shares of Common Stock. The Company plans to: (i) change its name to "Home Bistro, Inc." (the "Name Change"); (ii) request a change to its ticker symbol (the "New Symbol"); and (iii) effect a reverse stock split of its Common Stock at a ratio of approximately 1-for-32 shares (the "Reverse Split", together with the Name Change and New Symbol, the "Corporate Actions"). The Company intends to consummate the Corporate Actions as soon as possible and upon approval from the Secretary of State of the State of Nevada and the Financial Industry Regulatory Authority. Although the Company hopes to have all regulatory approvals on or before June 1, 2020, the Company can make no guarantees that it will receive any such approvals by that date. On April 20, 2020, pursuant to the terms of the Merger Agreement, Roy G. Warren, Jr., Mike Edwards and Bruce Zanca resigned as directors of the Company and Roy G. Warren, Jr. resigned as Chief Operating Officer of the Company. The resignations were not the result of any disagreement related to the Company's operations, policies or practices. Furthermore, on April 20, 2020, Mr. Zalmi Duchman, the Chief Executive Officer of Home Bistro, Michael Finkelstein and Michael Novielli were appointed as directors of the Company. In addition, Mr. Duchman was appointed Chief Executive Officer of the Company. Additionally, on April 20, 2020, the Company and a stockholder entered into a Put Option Agreement, pursuant to which, among other things, the Company agreed, at the election of the stockholder, to purchase certain shares of common stock held by the stockholder no sooner than two years from the date of the Put Option Agreement (the "Market Period"). Pursuant to the Put Option Agreement, in the event that the stockholder does not generate $1.3 million dollars (the "Total Investment") in gross proceeds from the sale of shares of common stock by the second anniversary of the Put Option Agreement, then the stockholder has the right to cause the Company to purchase shares held by the stockholder at a price equal to the difference between the Total Investment and the net proceeds actually realized by the stockholder from shares of common stock sold during the Market Period and the number of shares of common stock held by the stockholder on the date the put right is exercised. The put right expires fourteen (14) days from end of the Market Period .

Significant and Critical Acco_2

Significant and Critical Accounting Policies and Practices (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Basis of Presentation and principles of consolidation	Basis of Presentation and principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and in accordance with Regulation S-X of the Securities and Exchange Commission (the "SEC"). The consolidated financial statements present the consolidated financial statements of the Company and its wholly-owned subsidiary as of December 31, 2019 and 2018. All intercompany transactions and balances have been eliminated. These consolidated financial statements for the years ended December 31, 2019 and 2018 consist of the consolidated balance sheets of the Company as of December 31, 2019 and 2018, and the related consolidated statements of operations, statements of changes in stockholders' equity (deficit), and statements of cash flows for the years ended December 31, 2019 and 2018, and related notes, and accordingly do not reflect the acquisition of our new wholly-owned subsidiary, Home Bistro, which was consummated on April 20, 2020, as more fully disclosed in Note 13.
Use of Estimates and Assumptions and Critical Accounting Estimates	Use of Estimates and Assumptions and Critical Accounting Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated balance sheet, and revenues and expenses for the period then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to valuation of deferred tax assets and valuation of debt discounts.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassified amounts have no impact on the Company's previously reported financial position or results of operations.
Cash and cash equivalents	Cash and cash equivalents The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company held no cash equivalents as of December 31, 2019 and 2018. The Company maintains cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. The Company's account at this institution is insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. As of December 31, 2019 and 2018, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.
Fair value of financial instruments	Fair value of financial instruments The estimated fair value of certain financial instruments, including cash, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses, accrued salaries and related payroll liabilities, and convertible notes payable are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.
Inventory	Inventory The Company values inventory, consisting of finished goods and raw materials, at the lower of cost or net realizable value. Cost is determined on the first-in and first-out ("FIFO") method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of the estimated net realizable value include (i) estimates of future demand, and (ii) competitive pricing pressures. The Company recorded inventory write-off and spoilage of $14,309 and $0 during the year ended December 31, 2019 and 2018, respectively.
Property and Equipment	Property and Equipment Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets of 3 years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired, or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the consolidated statement of operations.
Revenue Recognition	Revenue Recognition On January 1, 2018, the Company adopted the Accounting Standard Codification ("ASC") Topic 606 and the related amendments Revenue from Contracts with Customers, which requires revenue to be recognized in a manner that depicts the transfer of goods or services to customers in amounts that reflect the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company recognizes revenue by applying the following steps: Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. The Company's performance obligations are satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company's contracts have a single performance obligation (shipment or delivery of product). The Company primarily receives fixed consideration for sales of product.
Cost of Sales	Cost of Sales The primary components of cost of sales include the cost of the product, production costs, warehouse storage costs and shipping fees.
Research and development	Research and development Research and development costs incurred in the development of the Company's products are expensed as incurred. During the years ended December 31, 2019 and 2018, research and development costs were $70,930 and $4,727, respectively.
Shipping and Handling Costs	Shipping and Handling Costs The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in selling and marketing expenses as incurred. Shipping costs included in selling and marketing expenses were $3,090 and $1,500 for the year ended December 31, 2019 and 2018, respectively.
Advertising Costs	Advertising Costs The Company applies ASC 720 "Other Expenses" to account for advertising related costs. Pursuant to ASC 720-35-25-1, the Company expenses the advertising costs the first time the advertising takes place. Advertising costs were $48,690 and $13,089 for the year ended December 31, 2019 and 2018, respectively, and was included in selling and marketing expenses.
Stock-based compensation	Stock-based compensation Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Through March 31, 2018, pursuant to ASC 505-50 - Equity-Based Payments to Non-Employees, all share-based payments to non-employees, including grants of stock options, were recognized in the consolidated financial statements as compensation expense over the service period of the consulting arrangement or until performance conditions were expected to be met. Using a Black Scholes valuation model, the Company periodically reassessed the fair value of non-employee options until service conditions were met, which generally aligned with the vesting period of the options, and the Company adjusted the expense recognized in the consolidated financial statements accordingly. In June 2018, the FASB issued ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting, which simplifies several aspects of the accounting for nonemployee share-based payment transactions by expanding the scope of the stock-based compensation guidance in ASC 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU No. 2018-07 is effective for annual periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption is permitted, but entities may not adopt prior to adopting the new revenue recognition guidance in ASC 606. Effective April 1, 2018, the Company adopted ASU No. 2018-07 which did not have any material impact on the Company's consolidated financial statements.
Leases	Leases In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases On January 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assessed whether the contract is, or contains, a lease. The Company's assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. Operating lease right of use assets ("ROU") assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses in the condensed consolidated statements of operations.
Income Taxes	Income Taxes The Company accounts for income taxes pursuant to the provision of ASC 740-10, "Accounting for Income Taxes" ("ASC 740-10"), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25, "Definition of Settlement", which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.
Impairment of long-lived assets	Impairment of long-lived assets The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset's estimated fair value and its book value. The Company recorded impairment expense of $24,899 and $0 during the year ended December 31, 2019 and 2018, respectively. The Company impaired the net book value of $24,899 related to equipment used for the production of the ready to drink tea beverage as the Company has shifted its focus on the product development of the Company's Keto complete meal beverage and was included in general and administrative expenses as reflected in the consolidated statements of operations.
Basic and diluted net loss per share	Basic and diluted net loss per share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The potentially dilutive common stock equivalents for the year ended December 31, 2019 and 2018 were excluded from the dilutive loss per share calculation as they would be antidilutive due to the net loss. The following were the computation of diluted shares outstanding and in periods where the Company has a net loss, all dilutive securities are excluded. December 31, December 31, Common stock equivalents: Stock options 1,940,000 1,940,000 Convertible notes payable 26,125,000 - Convertible Preferred Stock 267,250,000 111,000,000 Total 295,315,000 112,940,000
Recent accounting pronouncements	Recent accounting pronouncements In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)". The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. The new guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods and is applied retrospectively. The Company elected to apply the transition provisions as of January 1, 2019, the date of adoption, and recorded lease ROU assets and related liabilities on the consolidated balance sheet related to our operating leases. In July 2017, the FASB issued ASU 2017-11 "Earnings Per Share (Topic 260)". The amendments in the update change the classification of certain equity-linked financial instruments (or embedded features) with down round features. The amendments also clarify existing disclosure requirements for equity-classified instruments. For freestanding equity-classified financial instruments, the amendments require entities that present earnings per share ("EPS") in accordance with Topic 260, Earnings Per Share, to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features would be subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 with early adoption permitted. The Company adopted this pronouncement as of fiscal 2017 and applied it to the convertible notes payable issued in March and May of 2019 that include down round features. During the year ended December 31, 2019, a down round feature present in a convertible note payable and convertible preferred stock was triggered (see Notes 7 and 8). In June 2018, the FASB issued ASU No. 2018-07 "Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting." These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The ASU supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. The guidance is effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than a company's adoption date of Topic 606, Revenue from Contracts with Customers. The adoption of this guidance had no material impact on its accounting and disclosures. In August 2018, the FASB issued ASU 2018-13, "Changes to Disclosure Requirements for Fair Value Measurements", which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements, and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The adoption of this guidance had no material impact on its accounting and disclosures. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Significant and Critical Acco_3

Significant and Critical Accounting Policies and Practices (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Schedule of computation of diluted shares outstanding and all dilutive securities are excluded	December 31, December 31, Common stock equivalents: Stock options 1,940,000 1,940,000 Convertible notes payable 26,125,000 - Convertible Preferred Stock 267,250,000 111,000,000 Total 295,315,000 112,940,000

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2019
Inventory Disclosure [Abstract]
Schedule of inventory	December 31, December 31, Finished goods $ - $ 39,984 Raw materials - 20,132 $ - $ 60,116

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Estimated life As of As of Molding Tool equipment 3 years $ 30,592 $ 30,592 Packing equipment 3 years 19,756 19,756 Less: Accumulated depreciation (25,449 ) (12,861 ) Net book value (24,899 ) - Less: Impairment loss (24,899 ) - $ - $ 37,487

Operating Lease Right-of-Use _2

Operating Lease Right-of-Use Assets and Operating Lease Liabilities (Tables)	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Schedule of operating lease right-of-use assets	December 31, 2019 Office lease (remaining lease term of 18 months) $ 59,069 Equipment lease (remaining lease term of 27 months) 4,497 Subtotal 63,566 Less accumulated amortization (22,867 ) Right-of-use assets, net $ 40,699
Schedule of operating lease liabilities	December 31, 2019 Office lease $ 59,069 Equipment lease 4,497 Reduction of lease liability (22,867 ) Total lease liabilities 40,699 Less: current portion (25,612 ) Long term portion of lease liability $ 15,087
Schedule of minimum lease payments under non-cancelable operating lease	Year ended December 31, 2020 $ 28,764 Year ended December 31, 2021 15,450 Year ended December 31, 2022 435 Total $ 44,649 Less: present value discount (3,950 ) Total operating lease liability $ 40,699

Note payable and Convertible _2

Note payable and Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Schedule of convertible note payable	December 31, December 31, Convertible notes payable $ 1,045,000 $ - Unamortized debt discount (64,352 ) - Total convertible notes payable $ 980,648 $ -

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Schedule of stock option activity	Number of Weighted Weighted Aggregate Balance at December 31, 2017 - - - - Recapitalization on March 26, 2018 1,940,000 0.10 2.80 - Balance at December 31, 2018 1,940,000 0.10 2.79 - Options exercisable at December 31, 2018 1,940,000 $ 0.10 2.04 $ - Number of Weighted Weighted Aggregate Balance at December 31, 2018 1,940,000 0.10 2.04 - Balance at December 31, 2019 1,940,000 0.10 1.04 - Options exercisable at December 31, 2019 1,940,000 $ 0.10 1.04 $ -
Schedule of outstanding stock warrants	Number of Weighted Weighted Balance at December 31, 2017 12,000,000 $ 0.02 4.85 Granted 12,000,000 0.02 5.00 Cancelled (24,000,000 ) 0.10 4.70 Balance at December 31, 2018 - $ - - Warrants exercisable at December 31, 2018 - $ - - Weighted average fair value of warrants granted during the year ended December 31, 2018 $ 0.001

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Schedule of licensor minimum royalty payments	Payment Year $ 20,000 2018 $ 50,000 2019 $ 100,000 2020 and every year thereafter on the same date, for the life of this License Agreement.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of statutory rate and the provision for income taxes	Year Ended December 31, 2019 Year Ended December 31, 2018 Income tax benefit at U.S. statutory rate of 21% $ (246,434 ) $ (213,906 ) Non-deductible expenses 24,538 55,378 Increase in valuation allowance 221,896 158,528 Total provision for income tax $ - $ -
Schedule of components of the company's deferred tax assets	Deferred Tax Asset: December 31, 2019 December 31, 2018 Net operating loss carryforward $ 397,173 $ 175,277 Valuation allowance (397,173 ) (175,277 ) Net deferred tax asset $ - $ -

Organization and Operations (De

Organization and Operations (Details) - USD ($)	1 Months Ended
	Jun. 30, 2019	Mar. 31, 2018	Mar. 26, 2018
Organization and Operations (Textual)
Subsidiary shares of preferred stock percentage			86.00%
Common Stock [Member]
Organization and Operations (Textual)
Subsidiary shares of preferred stock percentage			85.84%
Common stock issued in exchange	250,000
Description of stock option			102,000,000
Series B Preferred Stock [Member]
Organization and Operations (Textual)
Preferred stock issued			500,000
Series A Preferred Stock [Member]
Organization and Operations (Textual)
Preferred stock issued			520,000
Series A Preferred Stock [Member]
Organization and Operations (Textual)
Purchase price		$ 2,000
Preferred stock issued		20,000
Description of stock option		In connection with the Exchange Agreement, the Company issued 500,000 Series A Preferred Stock for a purchase price of (i) $3,000 cash, (ii) the satisfaction of the convertible notes including accrued interest of $5,479 and total principal amount of $240,000 and the cancellation of all the stock warrants granted to the note holder pursuant to the Surrender and Exchange Agreement, (see Note 6) (iii) $260,000 additional funding in cash after the closing of an Exchange Agreement which is recorded as subscription receivable and (iv) the surrender and cancellation of certain notes and warrants owed by the Company prior to the merger pursuant to the Surrender and Exchange Agreement dated in March 2018 for a principal amount of $172,500 and accrued interest of $76,157. The subscription receivable of $260,000 was collected in April 2018. Such surrender of notes and warrants were done in connection with the Exchange Agreement which closed on March 26, 2018.
Spin Off Agreement [Member]
Organization and Operations (Textual)
Common stock issued in exchange			36,309,768

Significant and Critical Acco_4

Significant and Critical Accounting Policies and Practices (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	295,315,000	112,940,000
Common Stock [Member] | Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	267,250,000	111,000,000
Common Stock [Member] | Convertible notes payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	26,125,000
Common Stock [Member] | Stock options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,940,000	1,940,000

Significant and Critical Acco_5

Significant and Critical Accounting Policies and Practices (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Significant and Critical Accounting Policies and Practices (Textual)
Amount insured by the FDIC	$ 250,000
Advertising costs	48,690	$ 13,089
Shipping costs	$ 3,090	1,500
Tax benefit percentage, description	The largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.
Inventory write-off and spoilage	$ 14,309	22,648
Research and development costs	70,930	4,727
Impairment expense	24,899	$ 0
Net book value of impairment expense	$ 24,899
Estimated useful lives	P3Y

Going Concern (Details)

Going Concern (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Going Concern (Textual)
Accumulated deficit	$ (3,603,505)	$ (1,115,024)
Working capital deficit	1,046,000
Net loss	(1,173,493)	(1,018,600)
Cash used in operating activities	$ (877,617)	$ (758,859)

Inventory (Details)

Inventory (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished goods		$ 39,984
Raw materials		20,132
Total inventory		$ 60,116

Inventory (Details Textual)

Inventory (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Inventory (Textual)
Inventory held at third party locations		$ 60,116
Write-offs inventory	$ 14,309	$ 22,648

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Summary of property and equipment
Less: Accumulated depreciation	$ (25,449)	$ (12,861)
Net book value	(24,899)
Less: Impairment loss	(24,899)
Property and equipment, net		37,487
Molding Tool equipment [Member]
Summary of property and equipment
Estimated life	3 years
Property and equipment, gross	$ 30,592	30,592
Packing equipment [Member]
Summary of property and equipment
Estimated life	3 years
Property and equipment, gross	$ 19,756	$ 19,756

Property and Equipment (Detai_2

Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property and Equipment (Textual)
Depreciation expense	$ 12,588	$ 12,083
Impairment loss	(24,899)
Net book value of impairment expense	$ 24,899

Operating Lease Right-of-Use _3

Operating Lease Right-of-Use Assets and Operating Lease Liabilities (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Subtotal	$ 63,566
Less accumulated amortization	(22,867)
Right-of-use assets, net	$ 40,699
Office lease [Member]
Remaining lease term	18 months
Subtotal	$ 59,069
Equipment lease [Member]
Remaining lease term	27 months
Subtotal	$ 4,497

Operating Lease Right-of-Use _4

Operating Lease Right-of-Use Assets and Operating Lease Liabilities (Details 1) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Total lease liabilities	$ 40,699
Less: current portion	(25,612)
Long term portion of lease liability	15,087
Office lease [Member]
Total lease liabilities	59,069
Equipment lease [Member]
Total lease liabilities	4,497
Reduction of lease liability [Member]
Total lease liabilities	$ (22,867)

Operating Lease Right-of-Use _5

Operating Lease Right-of-Use Assets and Operating Lease Liabilities (Details 2)	Dec. 31, 2019USD ($)
Leases [Abstract]
Year ended December 31, 2020	$ 28,764
Year ended December 31, 2021	15,450
Year ended December 31, 2022	435
Total	44,649
Less: present value discount	(3,950)
Total operating lease liability	$ 40,699

Operating Lease Right-of-Use _6

Operating Lease Right-of-Use Assets and Operating Lease Liabilities (Details Textual) - USD ($)	1 Months Ended
	Mar. 31, 2019	Apr. 30, 2018	Dec. 31, 2019
Operating Lease Right-of-Use Assets and Operating Lease Liabilities (Textual)
Lease agreement description		The Company entered into a lease agreement for its corporate facility in Palm Beach Gardens, Florida. The lease is for a period of 36 months commencing in July 2018 and expiring in July 2021. Pursuant to the lease agreement, the lease requires the Company to pay a monthly base rent of $2,154 plus a pro rata share of operating expenses beginning July 2018 and subject to annual increases beginning the 2nd and 3rd lease year. In addition to the monthly base rent, we are charged separately for common area maintenance which is considered a non-lease component. These non-lease component payments are expensed as incurred and are not included in operating lease assets or liabilities.
Lease expiring date	Mar. 27, 2022
Option to purchase the equipment at fair market value	$ 145
Operating lease right-of-use assets and lease liabilities			$ 63,566

Note payable and Convertible _3

Note payable and Convertible Notes Payable (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Convertible notes payable	$ 1,045,000
Unamortized debt discount	(64,352)
Total convertible notes payable	$ 980,648

Note payable and Convertible _4

Note payable and Convertible Notes Payable (Details Textual) - USD ($)	Nov. 19, 2019	Oct. 11, 2019	Aug. 12, 2019	May 14, 2019	Mar. 07, 2019	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Feb. 13, 2019
Short-term Debt [Line Items]
Unrecognized compensation expense							$ 0
Maximum [Member]
Short-term Debt [Line Items]
Notes conversion price				$ .04
Minimum [Member]
Short-term Debt [Line Items]
Notes conversion price				$ .05
Second Allonge Agreement [Member]
Short-term Debt [Line Items]
Principal amount		$ 110,000
Cash proceeds		$ 100,000
Maturity date		Mar. 7, 2020
Original issue discount rate		10.00%
Allonge Agreement [Member]
Short-term Debt [Line Items]
Principal amount			$ 137,500
Cash proceeds			$ 125,000
Maturity date			Mar. 7, 2020
Conversion rate			$ 0.04
Original issue discount rate			10.00%
Securities Purchase Agreement [Member]
Short-term Debt [Line Items]
Description of financing transaction				The Company closed a financing transaction by entering into a Securities Purchase Agreement (the " Securities Purchase Agreement ") with an accredited investor for purchase of a promissory note (the "Note" and with other notes issued under the Securities Purchase Agreement, the "Notes") an aggregate principal amount of $550,000 and gross cash proceeds of $500,000 (out of an aggregate of up to $550,000 principal amount of Notes representing $1.10 of note principal for each $1.00 of proceeds which can be purchased in subsequent closings in minimum amounts of $25,000). The March 7, 2019 and May 14, 2019 promissory notes were convertible into common stock of the Company at an initial conversion price of $0.05 and $0.04, respectively, which is subject to price protection, whereby upon any issuance of securities of the Company at a price below the effective conversion price of the Notes is adjusted to the new lower issuance price ("Down Round Feature"). The Notes have a term of one year from the date of issuance. The Company received gross proceeds of $500,000 of which $50,000 was used to pay the promissory note issued in February 2019 (see above). See below for trigger of this Down Round Feature when the conversion price on the March 7, 2019 Securities Purchase Agreement was reduced from $0.05 to $0.04.	The Company closed a financing transaction by entering into a Securities Purchase Agreement (the " Securities Purchase Agreement ") with an accredited investor for purchase of a promissory note (the "Note" and with other notes issued under the Securities Purchase Agreement, the "Notes") an aggregate principal amount of $550,000 and gross cash proceeds of $500,000 (out of an aggregate of up to $550,000 principal amount of Notes representing $1.10 of note principal for each $1.00 of proceeds which can be purchased in subsequent closings in minimum amounts of $25,000). The March 7, 2019 and May 14, 2019 promissory notes were convertible into common stock of the Company at an initial conversion price of $0.05 and $0.04, respectively, which is subject to price protection, whereby upon any issuance of securities of the Company at a price below the effective conversion price of the Notes is adjusted to the new lower issuance price ("Down Round Feature"). The Notes have a term of one year from the date of issuance. The Company received gross proceeds of $500,000 of which $50,000 was used to pay the promissory note issued in February 2019 (see above). See below for trigger of this Down Round Feature when the conversion price on the March 7, 2019 Securities Purchase Agreement was reduced from $0.05 to $0.04.
Dividend declared to common stock				$ 72,188
Third Allonge Agreement [Member]
Short-term Debt [Line Items]
Principal amount	$ 247,500
Cash proceeds	$ 225,000
Maturity date	Mar. 7, 2020
Original issue discount rate	10.00%
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Descriptions of debt discount consisted							The debt discounts consisted of beneficial conversion features of $68,750, financing costs of $14,950, legal fees of $2,500 and debt premium of $95,000 which is being amortized over the term of the notes. During the year ended December 31, 2019 and 2018, the Company recorded $116,848 and $0, respectively, as amortization of debt discount which is included in interest expense in the consolidated statements of operations.
Unamortized discounts							$ 64,352	$ 0
Warrants purchase							26,125,000
Promissory Note [Member]
Short-term Debt [Line Items]
Annual interest rate						12.00%		12.00%	20.00%
Warrants term						5 years
Warrants issued to acquire number of shares						12,000,000
Warrants exercise price						$ 0.02
Notes conversion price						$ 0.01
Fair value of the warrants						$ 9,992
Years to maturity						5 years
Risk free rate						2.00%
Expected volatility						200.00%
Principal amount						$ 120,000		$ 240,000	$ 50,000
Amortization of debt discount								$ 29,703
Number of warrants cancelled								24,000,000
Accrued interest outstanding								$ 0
Accrued interest								547900.00%	10.00%

Stockholders' Equity (Deficit_2

Stockholders' Equity (Deficit) (Details) - Equity Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Summary of option activities
Number of Options, Beginning Balance	1,940,000
Number of Options, Recapitalization on March 26, 2018		1,940,000
Number of Options, Ending Balance	1,940,000	1,940,000
Number of Options, Exercisable	1,940,000	1,940,000
Weighted Average Exercise Price, Beginning Balance	$ 0.10
Weighted Average Exercise Price, Recapitalization on March 26, 2018		0.10
Weighted Average Exercise Price, Ending Balance	0.10	0.10
Weighted Average Exercise Price, Options exercisable	$ 0.10	$ 0.10
Weighted Average Remaining Contractual Life (Years), Beginning	2 years 15 days
Weighted Average Remaining Contractual Life (Years), Recapitalization on March 26, 2018		2 years 9 months 18 days
Weighted Average Remaining Contractual Life (Years), Ending	1 year 15 days	2 years 9 months 14 days
Weighted Average Remaining Contractual Life (Years), Options exercisable	1 year 15 days	2 years 15 days
Aggregate Intrinsic Value, Option outstanding, Beginning balance
Aggregate Intrinsic Value, Recapitalization
Aggregate Intrinsic Value, Option outstanding, Ending balance
Aggregate Intrinsic Value, Option exercisable

Stockholders' Equity (Deficit_3

Stockholders' Equity (Deficit) (Details 1) - Warrant [Member]	12 Months Ended
	Dec. 31, 2018$ / sharesshares
Summary of stock warrant activities
Number of Warrants, Beginning Balance | shares	12,000,000
Number of Warrants, Granted | shares	12,000,000
Number of Warrants, Cancelled | shares	(24,000,000)
Number of Warrants, Ending Balance | shares
Number of Warrants, Exercisable | shares
Weighted Average Exercise Price, Beginning Balance	$ 0.02
Weighted Average Exercise price, Granted	0.02
Weighted Average Exercise Price, Cancelled	0.10
Weighted Average Exercise Price, Ending Balance
Weighted Average Exercise Price, Exercisable
Weighted average fair value of warrants granted	$ 0.001
Weighted Average Remaining Contractual Life (Years)	4 years 10 months 6 days
Weighted Average Remaining Contractual Life (Years), Granted	5 years
Weighted Average Remaining Contractual Life (Years), Cancelled	4 years 8 months 12 days

Stockholders' Equity (Deficit_4

Stockholders' Equity (Deficit) (Details Textual) - USD ($)	Apr. 14, 2018	Jun. 30, 2019	Oct. 31, 2018	Aug. 31, 2018	Apr. 30, 2018	Mar. 26, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Aug. 09, 2019	May 14, 2019	Aug. 01, 2018	Mar. 19, 2018
Stockholders' Equity (Deficit) (Textual)
Common stock, shares authorized								1,000,000,000	1,000,000,000
Common stock, par value								$ 0.001	$ 0.001
Common stock, shares issued								17,082,065	16,832,065
Preferred stock, shares authorized								20,000,000	20,000,000
Preferred stock, par value								$ 0.001	$ 0.001
Stockholders equity, description								On August 9, 2019, the Board of Directors of the Company approved to increase the authorized shares of the Company's common stock to 600,000,000 shares from 300,000,000 shares of authorized shares of common stock.
Deemed dividend								$ 1,242,800
Stock based compensation									$ 234,000
Spin Off Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Common stock issued in exchange						36,309,768
Common Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Common stock, shares authorized								300,000,000
Common stock, par value								$ 0.001
Common stock, shares issued								2,600,000	2,600,000
Common stock issued in exchange		250,000
Common Stock [Member] | Consultants [Member]
Stockholders' Equity (Deficit) (Textual)
Number of stock issued					2,600,000
Stock issued fair value					$ 234,000
Common Stock [Member] | Spin Off Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Shares cancelled of common stock	36,309,768
Exchange Agreement [Member] | Common Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Number of stock issued								53,141,833
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized								2,500	2,500
Preferred stock, par value								$ 0.001	$ 0.001			$ 0.001
Preferred stock, shares issued								2,250	2,250
Number of stock issued								250
Share Price												$ 200
Common stock issued in exchange			750	750					750
Total proceeds			$ 150,000	$ 150,000					$ 150,000
Preferred stock designated shares												1,000
Preferred stock conversion price												$ 0.05
Decreasing conversion price											$ 0.04
Series C Preferred Stock [Member] | Board of Directors [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, description			In October 2018, the Board of Directors of the Company approved and authorized an amendment to increase the number of designated authorized shares of the Series C preferred stock from 1,000 to 2,500 shares.
Series A Preferred Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized								520,000	520,000
Preferred stock, par value								$ 0.001	$ 0.001				$ 0.001
Preferred stock, shares issued								519,000	520,000
Share Price													$ 10
Common stock conversion price		$ 1,000
Preferred stock designated shares													520,000
Preferred stock conversion price													$ 0.10
Decreasing conversion price											0.04
Series A Preferred Stock [Member] | Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares issued							490,000
Number of stock issued							20,000
Stock Purchase Price							$ 2,000
Total proceeds							263,000
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized								500,000	500,000
Preferred stock, par value								$ 0.001	$ 0.001				0.001
Preferred stock, shares issued								500,000	500,000
Share Price													$ 10
Preferred stock designated shares													500,000
Preferred stock conversion price													$ 0.10
Decreasing conversion price											$ 0.04
Convertible Notes [Member] | Exchange Agreement [Member]
Stockholders' Equity (Deficit) (Textual)
Total principal amount							240,000
Accrued interest							$ 5,479
Convertible notes percentage							12.00%
Board of Directors [Member]
Stockholders' Equity (Deficit) (Textual)
Common stock, shares authorized										300,000,000

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Dec. 31, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
2018	$ 20,000
2019	50,000
2020 and every year thereafter on the same date, for the life of this License Agreement.	$ 100,000

Commitments and Contingencies_3

Commitments and Contingencies (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Commitments and Contingencies (Textual)
License agreement commitments, description		(i) three percent (3%) for Net Sales of Licensed Products, and Licensed Processes (all as defined in the License Agreement), for each product or process, on a country-by-country basis, for cumulative Net Sales up to one million dollars ($1,000,000); and (ii) four percent (4%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, for cumulative Net Sales from one million dollars ($1,000,000) to five million dollars ($5,000,000); and (iii) five percent (5%) for Net Sales of Licensed Products and Licensed Processes, for each product or process, on a country-by-country basis, Net Sales over five million dollars ($5,000,000).
Royalty expense	$ 5,000
Payment of license issue fees	$ 5,000
Accrued royalty including accounts payable and accrued expenses		$ 60,000	$ 10,000

Concentrations of Revenue and_2

Concentrations of Revenue and Supplier (Details)	12 Months Ended
	Dec. 31, 2019USD ($)Customers	Dec. 31, 2018USD ($)Customers
Concentration risk, percentage	100.00%	45.00%
Purchased inventories | $	$ 3,424	$ 65,900
Number of vendors	2	2
Minimum [Member]
Concentration risk, percentage		12.00%
Maximum [Member]
Concentration risk, percentage		33.00%
Accounts Receivable [Member]
Concentration risk, percentage	100.00%	98.00%
Number of customers	2	2
Net Sales [Member]
Concentration risk, percentage	95.00%	99.00%
Number of customers	2	2

Related Party Transactions (Det

Related Party Transactions (Details) - shares	1 Months Ended
	Apr. 30, 2018	Dec. 31, 2019	Dec. 31, 2018
Related Party Transactions (Textual)
Description of related party transaction	The Company granted 100,000 shares of the Company's common stock to the son of the former CEO of the Company who is now the COO of the Company for services rendered (see Note 8). The Company valued these common shares at the fair value of $9,000 or $0.09 per common share based on the closing trading price on the date of grant. The Company recorded stock-based compensation of $9,000 during the year ended December 31, 2018. These shares were to be issued as of December 31, 2019.
Series B Preferred Stock [Member]
Related Party Transactions (Textual)
Preferred stock shares issued		500,000	500,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income tax benefit at U.S. statutory rate of 21%	$ (246,434)	$ (213,906)
Non-deductible expenses	24,538	55,378
Increase in valuation allowance	221,896	158,528
Total provision for income tax

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred Tax Asset:
Net operating loss carryforward	$ 397,173	$ 175,277
Valuation allowance	(397,173)	(175,277)
Net deferred tax asset

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	Dec. 22, 2017	Dec. 31, 2019	Dec. 31, 2018
Income Taxes (Textual)
Description on U.S. corporate federal income tax rate	The U.S. corporate federal income tax rate from a maximum of 35% to a flat 21% effective January 1, 2018.
Net operating losses		$ 1,891,301
Description for valuation allowance on deferred tax asset		The Company has provided a 100% valuation allowance on the deferred tax asset to reduce the asset to zero.
Increase in the allowance		$ 221,896	$ 158,528
U.S. statutory rate		21.00%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Apr. 20, 2020	Apr. 07, 2020	Jan. 30, 2020	Oct. 11, 2019	Mar. 24, 2020	Apr. 09, 2020	Dec. 31, 2019	Dec. 31, 2018	Mar. 19, 2018
Subsequent events (Textual)
Common stock, shares authorized							1,000,000,000	1,000,000,000
Preferred stock par value							$ 0.001	$ 0.001
Series B Preferred Stock [Member]
Subsequent events (Textual)
Preferred stock shares issued							500,000	500,000
Preferred stock shares outstanding							500,000	500,000
Preferred stock par value							$ 0.001	$ 0.001	$ 0.001
Subsequent Event [Member]
Subsequent events (Textual)
Number of shares issued	56,831,789				2,500,000
Gross proceed	$ 1,300,000				$ 25,000
Basis diluted common shares, description	The Merger, and subject to the terms and conditions of the Merger Agreement, each outstanding share of common stock of Home Bistro was converted into the right to receive fifteen thousand one hundred and point three (15,100.3) shares of common stock of the Company. Accordingly, the aggregate consideration issuable in the Merger to the former securityholders of Home Bistro is 767,838,260 shares of common stock on a fully-diluted basis consisting of 546,447,393 shares of common stock and warrants to purchase up to 221,390,867 shares of Common Stock. As a result of the Merger, the Company has 959,797,825 shares of common stock issued and outstanding on a fully-diluted basis consisting of 622,861,247 shares of common stock and warrants to purchase up to 336,936,578 shares of Common Stock. The Company plans to: (i) change its name to "Home Bistro, Inc." (the "Name Change"); (ii) request a change to its ticker symbol (the "New Symbol"); and (iii) effect a reverse stock split of its Common Stock at a ratio of approximately 1-for-32 shares (the "Reverse Split", together with the Name Change and New Symbol, the "Corporate Actions"). The Company intends to consummate the Corporate Actions as soon as possible and upon approval from the Secretary of State of the State of Nevada and the Financial Industry Regulatory Authority. Although the Company hopes to have all regulatory approvals on or before June 1, 2020, the Company can make no guarantees that it will receive any such approvals by that date.
Subsequent event, description		The Board of Directors of the Company approved to increase the authorized shares of the Company's common stock to 1,000,000,000 shares from 600,000,000 shares of authorized shares of common stock.
Common stock and warrants purchase	115,545,711
Subsequent Event [Member] | Series B Preferred Stock [Member]
Subsequent events (Textual)
Number of shares issued	172,377,500
Preferred stock shares issued	250,000					250,000
Preferred stock shares outstanding	250,000					250,000
Preferred stock par value	$ 0.001
Second Allonge Agreement [Member]
Subsequent events (Textual)
Principal amount				$ 110,000
Cash proceeds				$ 100,000
Maturity date				Mar. 7, 2020
Original issue discount rate				10.00%
Second Allonge Agreement [Member] | Subsequent Event [Member]
Subsequent events (Textual)
Principal amount			$ 82,500
Cash proceeds			$ 75,000
Maturity date			Mar. 7, 2020
Original issue discount rate			10.00%